A randomised phase III multicenter trial comparing irinotecan in combination with either the Nordic bolus 5FU and folinic acid (5FU/FA) schedule (FLIRI) or the bolus/infused de Gramont schedule (FOLFIRI), in patients with metastatic colorectal cancer

التفاصيل البيبلوغرافية
العنوان:	A randomised phase III multicenter trial comparing irinotecan in combination with either the Nordic bolus 5FU and folinic acid (5FU/FA) schedule (FLIRI) or the bolus/infused de Gramont schedule (FOLFIRI), in patients with metastatic colorectal cancer
المؤلفون:	Glimelius, B, Sorbye, H, Balteskard, L, Bystrom, P, Pfeiffer, P, Tveit, K, Heikkila, R, Keldsen, N, Albertsson, M, Starkhammar, H, Berglund, A
المصدر:	EJC SUPPLEMENTS. 3(2):167-167
مصطلحات موضوعية:	Medicin och hälsovetenskap
الوصول الحر:	http://kipublications.ki.se/Default.aspx?queryparsed=id:115486532Test
قاعدة البيانات:	SwePub

الوصف
تدمد:	13596349